In the March 2020 issue of Human Gene Therapy (vol. 31, nos. 3 and 4; 253–267), the article entitled “Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized RPGR Delivered by Subretinal Injection in a Canine Model of X-linked Retinitis Pigmentosa,” by Valérie L. Dufour et al., requires correction.
In the Funding Information section of the article, one grant number was omitted. The statement originally read as:
This work was supported by a Sponsored Research Agreement from AGTC, Inc. to the University of Pennsylvania, research grants from NIH/National Eye Institute R01-EY06855, P30-EY001583, and from the Foundation Fighting Blindness.
The statement should have read:
This work was supported by a Sponsored Research Agreement from AGTC, Inc. to the University of Pennsylvania, research grants from NIH/National Eye Institute R01-EY06855, P30-EY001583, RO1-EY017549, and from the Foundation Fighting Blindness.
The online version of the article has been corrected to reflect this. The authors apologize for this error.